期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Non-small molecule PROTACs(NSM-PROTACs):Protein degradation kaleidoscope 被引量:2
1
作者 Sinan Ma Jianai Ji +8 位作者 Yuanyuan Tong Yuxuan Zhu junwei dou Xian Zhang Shicheng Xu Tianbao Zhu Xiaoli Xu Qidong You Zhengyu Jiang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第7期2990-3005,共16页
The proteolysis targeting chimeras(PROTACs)technology has been rapidly developed since its birth in 2001,attracting rapidly growing attention of scientific institutes and pharmaceutical companies.At present,a variety ... The proteolysis targeting chimeras(PROTACs)technology has been rapidly developed since its birth in 2001,attracting rapidly growing attention of scientific institutes and pharmaceutical companies.At present,a variety of small molecule PROTACs have entered the clinical trial.However,as small molecule PROTACs flourish,non-small molecule PROTACs(NSM-PROTACs)such as peptide PROTACs,nucleic acid PROTACs and antibody PROTACs have also advanced considerably over recent years,exhibiting the unique characters beyond the small molecule PROTACs.Here,we briefly introduce the types of NSM-PROTACs,describe the advantages of NSM-PROTACs,and summarize the development of NSM-PROTACs so far in detail.We hope this article could not only provide useful insights into NSM-PROTACs,but also expand the research interest of NSM-PROTACs. 展开更多
关键词 Non-small molecule PROTACs Protein degradation Peptide PROTACs Nucleic acid PROTACs Antibody PROTACs
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部